Quintiles announces secondary public offering of about $545m worth of stock

Related tags Stock market

Quintiles announces secondary public offering of about $545m worth of stock
CRO Quintiles on Friday announced the pricing of a secondary public offering of 7,000,000 shares of its common stock at a price to the public of $77.85 per share, which is about $1 more per share than what the stock was selling for on Friday. 

The offering is being made by some existing shareholders, including investment funds associated with Bain Capital, affiliates of TPG Global, affiliates of 3i Corporation and Temasek Life Sciences.

Quintiles will not receive any proceeds from the sale of the shares in this offering.

Morgan Stanley is acting as the sole underwriter for this offering.

The offering is expected to close on August 5, 2015, subject to customary closing conditions. The company's stock fell about 3% on Friday.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars